Atara Biotherapeutics Inc (ATRA)
0.70
-0.01
(-2.06%)
USD |
NASDAQ |
Apr 25, 16:00
0.701
0.00 (0.00%)
After-Hours: 20:00
Atara Biotherapeutics Cash from Operations (TTM): -192.98M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -192.98M |
September 30, 2023 | -199.45M |
June 30, 2023 | -213.16M |
March 31, 2023 | -224.33M |
December 31, 2022 | -270.43M |
September 30, 2022 | -247.82M |
June 30, 2022 | -241.74M |
March 31, 2022 | -239.35M |
December 31, 2021 | -220.52M |
September 30, 2021 | -190.37M |
June 30, 2021 | -184.35M |
March 31, 2021 | -179.41M |
December 31, 2020 | -180.76M |
September 30, 2020 | -235.33M |
June 30, 2020 | -234.52M |
March 31, 2020 | -232.47M |
December 31, 2019 | -235.63M |
September 30, 2019 | -234.36M |
June 30, 2019 | -230.30M |
March 31, 2019 | -215.15M |
December 31, 2018 | -179.77M |
Date | Value |
---|---|
September 30, 2018 | -147.29M |
June 30, 2018 | -119.42M |
March 31, 2018 | -100.29M |
December 31, 2017 | -87.50M |
September 30, 2017 | -83.73M |
June 30, 2017 | -79.08M |
March 31, 2017 | -69.57M |
December 31, 2016 | -60.02M |
September 30, 2016 | -50.25M |
June 30, 2016 | -47.57M |
March 31, 2016 | -43.02M |
December 31, 2015 | -37.16M |
September 30, 2015 | -30.72M |
June 30, 2015 | -21.91M |
March 31, 2015 | -20.33M |
December 31, 2014 | -16.63M |
September 30, 2014 | -14.16M |
June 30, 2014 | -11.76M |
March 31, 2014 | -5.966M |
December 31, 2013 | -5.966M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-270.43M
Minimum
Dec 2022
-179.41M
Maximum
Mar 2021
-220.38M
Average
-230.30M
Median
Jun 2019
Cash from Operations (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.00M |
Oragenics Inc | -7.291M |